Metropolitan Life Insurance Company (MetLife)’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-121
| Closed | -$112K | – | 2642 |
|
|
2019
Q2 | $112K | Hold |
121
| – | – | ﹤0.01% | 2243 |
|
|
2019
Q1 | $193K | Hold |
121
| – | – | ﹤0.01% | 1916 |
|
|
2018
Q4 | $227K | Hold |
121
| – | – | ﹤0.01% | 1730 |
|
|
2018
Q3 | $286K | Hold |
121
| – | – | ﹤0.01% | 1746 |
|
|
2018
Q2 | $417K | Hold |
121
| – | – | 0.01% | 1441 |
|
|
2018
Q1 | $344K | Buy |
121
+3
| +3% | +$8.53K | ﹤0.01% | 1520 |
|
|
2017
Q4 | $303K | Sell |
118
-131
| -53% | -$336K | ﹤0.01% | 1611 |
|
|
2017
Q3 | $707K | Hold |
249
| – | – | ﹤0.01% | 1462 |
|
|
2017
Q2 | $589K | Hold |
249
| – | – | ﹤0.01% | 1569 |
|
|
2017
Q1 | $628K | Sell |
249
-9
| -3% | -$22.7K | ﹤0.01% | 1500 |
|
|
2016
Q4 | $582K | Hold |
258
| – | – | ﹤0.01% | 1640 |
|
|
2016
Q3 | $646K | Hold |
258
| – | – | ﹤0.01% | 1540 |
|
|
2016
Q2 | $789K | Hold |
258
| – | – | 0.01% | 1400 |
|
|
2016
Q1 | $819K | Buy |
258
+8
| +3% | +$25.4K | 0.01% | 1274 |
|
|
2015
Q4 | $1.28M | Sell |
250
-5
| -2% | -$25.6K | 0.01% | 1058 |
|
|
2015
Q3 | $813K | Hold |
255
| – | – | 0.01% | 1302 |
|
|
2015
Q2 | $1.02M | Sell |
255
-14
| -5% | -$56.1K | 0.01% | 1269 |
|
|
2015
Q1 | $1.07M | Sell |
269
-1
| -0.4% | -$3.99K | 0.01% | 1167 |
|
|
2014
Q4 | $1.33M | Hold |
270
| – | – | 0.01% | 1160 |
|
|
2014
Q3 | $1.1M | Hold |
270
| – | – | 0.01% | 1218 |
|
|
2014
Q2 | $1.09M | Hold |
270
| – | – | 0.01% | 1294 |
|
|
2014
Q1 | $1.23M | Hold |
270
| – | – | 0.01% | 1206 |
|
|
2013
Q4 | $948K | Hold |
270
| – | – | 0.01% | 1366 |
|
|
2013
Q3 | $1.11M | Hold |
270
| – | – | 0.01% | 1223 |
|
|
2013
Q2 | $1.07M | Buy |
+270
| New | +$1.07M | 0.01% | 1192 |
|